G-四重複結合ベンゾ[a]フェノキサジンは,ヒト胃がん細胞におけるc-KIT発現を低下調節する
Keith I E McLuckie1, Zoë A E Waller, Deborah A Sanders
1Department of Chemistry, University of Cambridge, Cambridge, UK.
Journal of the American Chemical Society
|February 8, 2011
まとめ
研究者らは,c-KIT遺伝子転写を低下させる新しいG-四重複合リガンドを発見した. これらの化合物,ベンゾ[a]フェノキサジン誘導体は,G-四重複構造を標的にすることで,抗腫瘍剤としての可能性を示しています.
科学分野:
- 分子生物学は分子生物学である.
- 薬用化学 薬用化学について
- 遺伝学 遺伝学とは
背景:
- G-四重複 (G4) 構造は,細胞機能と治療の可能性における役割により,重要な関心を持つ核酸二次構造です.
- G4モチーフは,遺伝子プロモーター領域で頻繁に発見され,G4形成と遺伝子転写制御の間の関連性を示唆しています.
研究 の 目的:
- 遺伝子転写を調節できる新しいG-四重複合リガンドを特定する.
- これらのリガンドの治療薬としての可能性を調査し,特にc-KIT腫瘍遺伝子をターゲットにします.
主な方法:
- G-quadruplex リガンドをスクリーニングするために,機能的な細胞ベースの測定法を使用しました.
- G-クアドルプレックスを含むc-KITプロモーターによって駆動されるルシフェラーゼレポーターシステムを採用した.
- ヒト胃がん細胞系における内在的なc-KIT発現に対する特定されたリガンドの効果を検証した.
- 表面プラズモン共鳴 (SPR) を使用した生体物理分析を行い,リガンド結合親和性と選択性を評価した.
主要な成果:
- c-KITプロモーターからの転写を大幅に減少させる2つの新しいG-四重複素リガンドを特定しました.
- これらのリガンドは,胃がん細胞における内在的なc-KIT発現を低下させることを実証した.
- c-KITプロモーター内の特定のG-四重複構造に対するリガンドの高親和性と優先結合が,二重鎖DNAと比較して確認された.
結論:
- 細胞ベースのレポーターアッセイは,転写を調節するG-四重複結合分子を発見するのに有効です.
- ベンゾ[a]フェノキサジン誘導体は,G-四重複構造を標的とする有望な化合物クラスです.
- これらの発見は,抗腫瘍剤,特にc-KITを含むがんに対する抗腫瘍剤としての可能性を持つ新しいG-四重複合体リガンドを特定します.
関連する概念動画
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...


